ID   POL_RSVP                Reviewed;        1603 AA.
AC   P03354; O92805; Q07462; Q64983;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   10-AUG-2010, sequence version 2.
DT   22-JUL-2015, entry version 123.
DE   RecName: Full=Gag-Pro-Pol polyprotein;
DE   Contains:
DE     RecName: Full=Matrix protein p19;
DE   Contains:
DE     RecName: Full=p2A;
DE   Contains:
DE     RecName: Full=p2B;
DE   Contains:
DE     RecName: Full=p10;
DE   Contains:
DE     RecName: Full=Capsid protein p27;
DE   Contains:
DE     RecName: Full=p3;
DE   Contains:
DE     RecName: Full=Nucleocapsid protein p12;
DE   Contains:
DE     RecName: Full=Protease p15;
DE              EC=3.4.23.-;
DE   Contains:
DE     RecName: Full=Reverse transcriptase beta-subunit;
DE              Short=RT-beta;
DE              EC=2.7.7.49;
DE              EC=2.7.7.7;
DE              EC=3.1.26.4;
DE   Contains:
DE     RecName: Full=Reverse transcriptase alpha-subunit;
DE              Short=RT-alpha;
DE              EC=2.7.7.49;
DE              EC=2.7.7.7;
DE              EC=3.1.26.4;
DE   Contains:
DE     RecName: Full=Integrase;
DE              Short=IN;
DE     AltName: Full=pp32;
DE   Contains:
DE     RecName: Full=p4;
GN   Name=gag-pro-pol;
OS   Rous sarcoma virus (strain Prague C) (RSV-PrC).
OC   Viruses; Retro-transcribing viruses; Retroviridae; Orthoretrovirinae;
OC   Alpharetrovirus.
OX   NCBI_TaxID=11888;
OH   NCBI_TaxID=9031; Gallus gallus (Chicken).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6299578; DOI=10.1016/0092-8674(83)90071-5;
RA   Schwartz D., Tizard R., Gilbert W.;
RT   "Nucleotide sequence of Rous sarcoma virus.";
RL   Cell 32:853-869(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA], AND POST-TRANSLATIONAL
RP   MODIFICATIONS.
RX   PubMed=2982497; DOI=10.1016/0092-8674(85)90202-8;
RA   Broome S., Gilbert W.;
RT   "Rous sarcoma virus encodes a transcriptional activator.";
RL   Cell 40:537-546(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8387633;
RA   Kashuba V.I., Kavsan V.M., Ryndich A.V., Lazurkevich Z.V., Zubak S.V.,
RA   Popov S.V., Dostalova V., Glozhanek I.;
RT   "Complete nucleotide sequence of Rous sarcoma virus variants adapted
RT   to duck cells.";
RL   Mol. Biol. (Mosk.) 27:436-450(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RA   Chappey C.;
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEOLYTIC PROCESSING OF POLYPROTEIN.
RX   PubMed=8636100; DOI=10.1074/jbc.271.12.6781;
RA   Tozser J., Bagossi P., Weber I.T., Copeland T.D., Oroszlan S.;
RT   "Comparative studies on the substrate specificity of avian
RT   myeloblastosis virus proteinase and lentiviral proteinases.";
RL   J. Biol. Chem. 271:6781-6788(1996).
RN   [6]
RP   SUBUNIT.
RX   PubMed=10708441; DOI=10.1128/JVI.74.7.3245-3252.2000;
RA   Werner S., Woehrl B.M.;
RT   "Asymmetric subunit organization of heterodimeric Rous sarcoma virus
RT   reverse transcriptase alphabeta: localization of the polymerase and
RT   RNase H active sites in the alpha subunit.";
RL   J. Virol. 74:3245-3252(2000).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 578-701 OF MUTANT SER-615;
RP   ILE-619; ILE-621; MET-650; ALA-677; VAL-681; ARG-682; GLY-683; SER-684
RP   WITH INHIBITOR.
RX   PubMed=9521772; DOI=10.1021/bi972183g;
RA   Wu J., Adomat J.M., Ridky T.W., Louis J.M., Leis J., Harrison R.W.,
RA   Weber I.T.;
RT   "Structural basis for specificity of retroviral proteases.";
RL   Biochemistry 37:4518-4526(1998).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.53 ANGSTROMS) OF 1329-1566.
RC   STRAIN=Clone pATV8;
RX   PubMed=10669607; DOI=10.1006/jmbi.1999.3463;
RA   Yang Z.-N., Mueser T.C., Bushman F.D., Hyde C.C.;
RT   "Crystal structure of an active two-domain derivative of Rous sarcoma
RT   virus integrase.";
RL   J. Mol. Biol. 296:535-548(2000).
CC   -!- FUNCTION: Capsid protein p27 forms the spherical core of the virus
CC       that encapsulates the genomic RNA-nucleocapsid complex.
CC       {ECO:0000250}.
CC   -!- FUNCTION: The aspartyl protease mediates proteolytic cleavages of
CC       Gag and Gag-Pol polyproteins during or shortly after the release
CC       of the virion from the plasma membrane. Cleavages take place as an
CC       ordered, step-wise cascade to yield mature proteins. This process
CC       is called maturation. Displays maximal activity during the budding
CC       process just prior to particle release from the cell.
CC       {ECO:0000255|PROSITE-ProRule:PRU00275}.
CC   -!- CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) =
CC       diphosphate + DNA(n+1). {ECO:0000255|PROSITE-ProRule:PRU00405}.
CC   -!- CATALYTIC ACTIVITY: Endonucleolytic cleavage to 5'-
CC       phosphomonoester. {ECO:0000255|PROSITE-ProRule:PRU00408}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 2 magnesium ions for reverse transcriptase polymerase
CC       activity. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 2 magnesium ions for ribonuclease H (RNase H) activity.
CC       Substrate-binding is a precondition for magnesium binding.
CC       {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 8 Mg(2+) ions per integrase homotetramer.
CC       {ECO:0000250};
CC   -!- SUBUNIT: The protease is active as a homodimer (By similarity).
CC       The integrase forms a homotetramer. Reverse transcriptase is a
CC       heterodimer of alpha and beta subunits. Three forms of RT exist:
CC       alpha-alpha (alpha-Pol), beta-beta (beta-Pol), and alpha-beta,
CC       with the major form being the heterodimer. Both the polymerase and
CC       RNase H active sites are located in the alpha subunit of
CC       heterodimeric RT alpha-beta. {ECO:0000250,
CC       ECO:0000269|PubMed:10708441}.
CC   -!- SUBCELLULAR LOCATION: Matrix protein p19: Virion {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Capsid protein p27: Virion {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleocapsid protein p12: Virion
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Ribosomal frameshifting; Named isoforms=2;
CC         Comment=Translation results in the formation of the Gag-Pro.
CC         Ribosomal frameshifting at the gag-pro/pol genes boundary
CC         produces the Gag-Pro-Pol polyprotein.;
CC       Name=Gag-Pro-Pol polyprotein;
CC         IsoId=P03354-1; Sequence=Displayed;
CC         Note=Produced by -1 ribosomal frameshifting.;
CC       Name=Gag-Pro polyprotein;
CC         IsoId=P03322-1; Sequence=External;
CC         Note=Produced by conventional translation.;
CC   -!- DOMAIN: Late-budding domains (L domains) are short sequence motifs
CC       essential for viral particle release. They can occur individually
CC       or in close proximity within structural proteins. They interacts
CC       with sorting cellular proteins of the multivesicular body (MVB)
CC       pathway. Most of these proteins are class E vacuolar protein
CC       sorting factors belonging to ESCRT-I, ESCRT-II or ESCRT-III
CC       complexes. P2B contains one L domain: a PPXY motif which probably
CC       binds to the WW domains of HECT (homologous to E6-AP C-terminus)
CC       E3 ubiquitin ligases (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: Integrase core domain contains the D-x(n)-D-x(35)-E motif,
CC       named for the phylogenetically conserved glutamic acid and
CC       aspartic acid residues and the invariant 35 amino acid spacing
CC       between the second and third acidic residues. Each acidic residue
CC       of the D,D(35)E motif is independently essential for the 3'-
CC       processing and strand transfer activities of purified integrase
CC       protein (By similarity). {ECO:0000250}.
CC   -!- PTM: Specific enzymatic cleavages in vivo yield mature proteins.
CC       {ECO:0000269|PubMed:8636100}.
CC   -!- MISCELLANEOUS: The reverse transcriptase is an error-prone enzyme
CC       that lacks a proof-reading function. High mutations rate is a
CC       direct consequence of this characteristic. RT also displays
CC       frequent template switching leading to high recombination rate.
CC       Recombination mostly occurs between homologous regions of the two
CC       copackaged RNA genomes. If these two RNA molecules derive from
CC       different viral strains, reverse transcription will give rise to
CC       highly recombinated proviral DNAs.
CC   -!- SIMILARITY: Contains 2 CCHC-type zinc fingers.
CC       {ECO:0000255|PROSITE-ProRule:PRU00047}.
CC   -!- SIMILARITY: Contains 1 integrase catalytic domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00457}.
CC   -!- SIMILARITY: Contains 1 integrase-type DNA-binding domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00506}.
CC   -!- SIMILARITY: Contains 1 integrase-type zinc finger.
CC       {ECO:0000255|PROSITE-ProRule:PRU00450}.
CC   -!- SIMILARITY: Contains 1 peptidase A2 domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00275}.
CC   -!- SIMILARITY: Contains 1 reverse transcriptase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00405}.
CC   -!- SIMILARITY: Contains 1 RNase H domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00408}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB59933.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; V01197; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; J02342; AAB59933.1; ALT_INIT; Genomic_RNA.
DR   EMBL; X68524; CAA48535.1; -; Genomic_DNA.
DR   EMBL; AF033808; AAC82561.1; -; Genomic_RNA.
DR   PIR; A03955; GNFV1R.
DR   RefSeq; NP_056886.1; NC_001407.1.
DR   PDB; 1BAI; X-ray; 2.4 A; A/B=578-701.
DR   PDB; 1C0M; X-ray; 2.53 A; A/B/C/D=1329-1566.
DR   PDB; 1C1A; X-ray; 3.10 A; A/B=1329-1566.
DR   PDB; 3TIR; X-ray; 4.10 A; A=240-465.
DR   PDB; 4FW1; X-ray; 1.86 A; A/B=1329-1550.
DR   PDB; 4FW2; X-ray; 2.65 A; A/B=1281-1550.
DR   PDBsum; 1BAI; -.
DR   PDBsum; 1C0M; -.
DR   PDBsum; 1C1A; -.
DR   PDBsum; 3TIR; -.
DR   PDBsum; 4FW1; -.
DR   PDBsum; 4FW2; -.
DR   ProteinModelPortal; P03354; -.
DR   SMR; P03354; 2-87, 214-469, 503-552, 578-701, 1329-1550.
DR   MINT; MINT-214692; -.
DR   BindingDB; P03354; -.
DR   ChEMBL; CHEMBL2750; -.
DR   GeneID; 2193432; -.
DR   EvolutionaryTrace; P03354; -.
DR   PMAP-CutDB; O92805; -.
DR   Proteomes; UP000007183; Genome.
DR   GO; GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-KW.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0015074; P:DNA integration; IEA:UniProtKB-KW.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0075713; P:establishment of integrated proviral latency; IEA:UniProtKB-KW.
DR   GO; GO:0046718; P:viral entry into host cell; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.200; -; 1.
DR   Gene3D; 1.10.1200.30; -; 1.
DR   Gene3D; 1.10.150.90; -; 1.
DR   Gene3D; 1.10.375.10; -; 1.
DR   Gene3D; 2.30.30.10; -; 1.
DR   Gene3D; 2.40.70.10; -; 1.
DR   Gene3D; 3.30.420.10; -; 2.
DR   Gene3D; 4.10.60.10; -; 1.
DR   InterPro; IPR001969; Aspartic_peptidase_AS.
DR   InterPro; IPR004028; Gag_M.
DR   InterPro; IPR000721; Gag_p24.
DR   InterPro; IPR001037; Integrase_C_retrovir.
DR   InterPro; IPR001584; Integrase_cat-core.
DR   InterPro; IPR017856; Integrase_Zn-bd_dom-like_N.
DR   InterPro; IPR003308; Integrase_Zn-bd_dom_N.
DR   InterPro; IPR012344; Matrix_HIV/RSV.
DR   InterPro; IPR018061; Pept_A2A_retrovirus_sg.
DR   InterPro; IPR001995; Peptidase_A2_cat.
DR   InterPro; IPR021109; Peptidase_aspartic_dom.
DR   InterPro; IPR008916; Retrov_capsid_C.
DR   InterPro; IPR008919; Retrov_capsid_N.
DR   InterPro; IPR010999; Retrovr_matrix.
DR   InterPro; IPR012337; RNaseH-like_dom.
DR   InterPro; IPR002156; RNaseH_domain.
DR   InterPro; IPR000477; RT_dom.
DR   InterPro; IPR001878; Znf_CCHC.
DR   Pfam; PF00607; Gag_p24; 1.
DR   Pfam; PF00552; IN_DBD_C; 1.
DR   Pfam; PF02022; Integrase_Zn; 1.
DR   Pfam; PF02813; Retro_M; 1.
DR   Pfam; PF00075; RNase_H; 1.
DR   Pfam; PF00665; rve; 1.
DR   Pfam; PF00077; RVP; 1.
DR   Pfam; PF00078; RVT_1; 1.
DR   Pfam; PF00098; zf-CCHC; 1.
DR   ProDom; PD002871; Gag_M; 1.
DR   SMART; SM00343; ZnF_C2HC; 2.
DR   SUPFAM; SSF46919; SSF46919; 1.
DR   SUPFAM; SSF47353; SSF47353; 1.
DR   SUPFAM; SSF47836; SSF47836; 1.
DR   SUPFAM; SSF47943; SSF47943; 1.
DR   SUPFAM; SSF50122; SSF50122; 1.
DR   SUPFAM; SSF50630; SSF50630; 1.
DR   SUPFAM; SSF53098; SSF53098; 2.
DR   SUPFAM; SSF57756; SSF57756; 1.
DR   PROSITE; PS50175; ASP_PROT_RETROV; 1.
DR   PROSITE; PS00141; ASP_PROTEASE; 1.
DR   PROSITE; PS50994; INTEGRASE; 1.
DR   PROSITE; PS51027; INTEGRASE_DBD; 1.
DR   PROSITE; PS50879; RNASE_H; 1.
DR   PROSITE; PS50878; RT_POL; 1.
DR   PROSITE; PS50158; ZF_CCHC; 1.
DR   PROSITE; PS50876; ZF_INTEGRASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aspartyl protease; Capsid protein; Complete proteome;
KW   DNA integration; DNA recombination; DNA-binding;
KW   DNA-directed DNA polymerase; Endonuclease; Hydrolase; Magnesium;
KW   Metal-binding; Multifunctional enzyme; Nuclease;
KW   Nucleotidyltransferase; Protease; Repeat; Ribosomal frameshifting;
KW   RNA-binding; RNA-directed DNA polymerase; Transferase;
KW   Viral genome integration; Viral nucleoprotein; Virion;
KW   Virus entry into host cell; Zinc; Zinc-finger.
FT   CHAIN         1    155       Matrix protein p19.
FT                                /FTId=PRO_5000053588.
FT   CHAIN       156    166       p2A.
FT                                /FTId=PRO_0000397068.
FT   CHAIN       167    177       p2B.
FT                                /FTId=PRO_0000397069.
FT   CHAIN       178    239       p10.
FT                                /FTId=PRO_5000053589.
FT   CHAIN       240    479       Capsid protein p27.
FT                                /FTId=PRO_5000053590.
FT   CHAIN       480    488       p3.
FT                                /FTId=PRO_0000397070.
FT   CHAIN       489    577       Nucleocapsid protein p12.
FT                                /FTId=PRO_5000053591.
FT   CHAIN       578    708       Protease p15.
FT                                /FTId=PRO_5000053592.
FT   CHAIN       709   1567       Reverse transcriptase beta-subunit.
FT                                /FTId=PRO_0000397071.
FT   CHAIN       709   1280       Reverse transcriptase alpha-subunit.
FT                                /FTId=PRO_0000040986.
FT   CHAIN      1281   1567       Integrase.
FT                                /FTId=PRO_0000040987.
FT   CHAIN      1568   1603       p4.
FT                                /FTId=PRO_0000397072.
FT   DOMAIN      609    690       Peptidase A2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00275}.
FT   DOMAIN      750    938       Reverse transcriptase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00405}.
FT   DOMAIN     1149   1280       RNase H. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00408}.
FT   DOMAIN     1333   1496       Integrase catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00457}.
FT   ZN_FING     507    524       CCHC-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING     533    550       CCHC-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   ZN_FING    1280   1321       Integrase-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00450}.
FT   DNA_BIND   1502   1550       Integrase-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00506}.
FT   MOTIF       172    175       PPXY motif. {ECO:0000250}.
FT   COMPBIAS    171    174       Poly-Pro.
FT   ACT_SITE    614    614       For protease activity; shared with
FT                                dimeric partner. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10094}.
FT   METAL       815    815       Magnesium; catalytic; for reverse
FT                                transcriptase activity. {ECO:0000250}.
FT   METAL       890    890       Magnesium; catalytic; for reverse
FT                                transcriptase activity. {ECO:0000250}.
FT   METAL       891    891       Magnesium; catalytic; for reverse
FT                                transcriptase activity. {ECO:0000250}.
FT   METAL      1158   1158       Magnesium; catalytic; for RNase H
FT                                activity. {ECO:0000250}.
FT   METAL      1192   1192       Magnesium; catalytic; for RNase H
FT                                activity. {ECO:0000250}.
FT   METAL      1213   1213       Magnesium; catalytic; for RNase H
FT                                activity. {ECO:0000250}.
FT   METAL      1272   1272       Magnesium; catalytic; for RNase H
FT                                activity. {ECO:0000250}.
FT   METAL      1344   1344       Magnesium; catalytic; for integrase
FT                                activity. {ECO:0000250}.
FT   METAL      1401   1401       Magnesium; catalytic; for integrase
FT                                activity. {ECO:0000250}.
FT   METAL      1437   1437       Magnesium; catalytic; for integrase
FT                                activity. {ECO:0000250}.
FT   SITE        155    156       Cleavage; by viral protease p15.
FT   SITE        166    167       Cleavage; by viral protease p15.
FT   SITE        177    178       Cleavage; by viral protease p15.
FT   SITE        239    240       Cleavage; by viral protease p15.
FT   SITE        479    480       Cleavage; by viral protease p15.
FT   SITE        488    489       Cleavage; by viral protease p15.
FT   SITE        577    578       Cleavage; by viral protease p15.
FT   SITE        708    709       Cleavage; by viral protease p15.
FT   SITE       1280   1281       Cleavage; by viral protease p15.
FT   SITE       1567   1568       Cleavage; by viral protease p15.
FT   VARIANT     722    722       P -> S.
FT   VARIANT     724    724       H -> R.
FT   VARIANT     884    884       C -> R.
FT   VARIANT     907    907       E -> K.
FT   VARIANT     955    955       A -> T.
FT   VARIANT    1012   1012       R -> Q.
FT   VARIANT    1182   1182       A -> V.
FT   VARIANT    1243   1243       S -> G.
FT   VARIANT    1575   1575       E -> G.
FT   VARIANT    1577   1577       E -> K.
FT   CONFLICT    756    756       E -> V (in Ref. 3; CAA48535).
FT                                {ECO:0000305}.
FT   CONFLICT   1206   1206       T -> A (in Ref. 3; CAA48535).
FT                                {ECO:0000305}.
FT   CONFLICT   1274   1274       Q -> K (in Ref. 3; CAA48535).
FT                                {ECO:0000305}.
FT   CONFLICT   1381   1381       V -> A (in Ref. 3; CAA48535).
FT                                {ECO:0000305}.
FT   STRAND     1339   1347       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1349   1351       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1356   1362       {ECO:0000244|PDB:4FW1}.
FT   TURN       1363   1365       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1368   1375       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1378   1392       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1396   1400       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1404   1407       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1409   1418       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1421   1424       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1430   1433       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1435   1453       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1457   1459       {ECO:0000244|PDB:1C0M}.
FT   HELIX      1462   1464       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1465   1478       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1488   1493       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1503   1507       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1509   1511       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1513   1522       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1524   1531       {ECO:0000244|PDB:4FW1}.
FT   TURN       1532   1534       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1537   1541       {ECO:0000244|PDB:4FW1}.
FT   HELIX      1542   1544       {ECO:0000244|PDB:4FW1}.
FT   STRAND     1545   1547       {ECO:0000244|PDB:4FW1}.
SQ   SEQUENCE   1603 AA;  173881 MW;  01AF800FDF929CB6 CRC64;
     MEAVIKVISS ACKTYCGKTS PSKKEIGAML SLLQKEGLLM SPSDLYSPGS WDPITAALSQ
     RAMILGKSGE LKTWGLVLGA LKAAREEQVT SEQAKFWLGL GGGRVSPPGP ECIEKPATER
     RIDKGEEVGE TTVQRDAKMA PEETATPKTV GTSCYHCGTA IGCNCATASA PPPPYVGSGL
     YPSLAGVGEQ QGQGGDTPPG AEQSRAEPGH AGQAPGPALT DWARVREELA STGPPVVAMP
     VVIKTEGPAW TPLEPKLITR LADTVRTKGL RSPITMAEVE ALMSSPLLPH DVTNLMRVIL
     GPAPYALWMD AWGVQLQTVI AAATRDPRHP ANGQGRGERT NLNRLKGLAD GMVGNPQGQA
     ALLRPGELVA ITASALQAFR EVARLAEPAG PWADIMQGPS ESFVDFANRL IKAVEGSDLP
     PSARAPVIID CFRQKSQPDI QQLIRTAPST LTTPGEIIKY VLDRQKTAPL TDQGIAAAMS
     SAIQPLIMAV VNRERDGQTG SGGRARGLCY TCGSPGHYQA QCPKKRKSGN SRERCQLCNG
     MGHNAKQCRK RDGNQGQRPG KGLSSGPWPG PEPPAVSLAM TMEHKDRPLV RVILTNTGSH
     PVKQRSVYIT ALLDSGADIT IISEEDWPTD WPVMEAANPQ IHGIGGGIPM RKSRDMIELG
     VINRDGSLER PLLLFPAVAM VRGSILGRDC LQGLGLRLTN LIGRATVLTV ALHLAIPLKW
     KPDHTPVWID QWPLPEGKLV ALTQLVEKEL QLGHIEPSLS CWNTPVFVIR KASGSYRLLH
     DLRAVNAKLV PFGAVQQGAP VLSALPRGWP LMVLDLKDCF FSIPLAEQDR EAFAFTLPSV
     NNQAPARRFQ WKVLPQGMTC SPTICQLVVG QVLEPLRLKH PSLCMLHYMD DLLLAASSHD
     GLEAAGEEVI STLERAGFTI SPDKVQREPG VQYLGYKLGS TYVAPVGLVA EPRIATLWDV
     QKLVGSLQWL RPALGIPPRL MGPFYEQLRG SDPNEAREWN LDMKMAWREI VRLSTTAALE
     RWDPALPLEG AVARCEQGAI GVLGQGLSTH PRPCLWLFST QPTKAFTAWL EVLTLLITKL
     RASAVRTFGK EVDILLLPAC FREDLPLPEG ILLALKGFAG KIRSSDTPSI FDIARPLHVS
     LKVRVTDHPV PGPTVFTDAS SSTHKGVVVW REGPRWEIKE IADLGASVQQ LEARAVAMAL
     LLWPTTPTNV VTDSAFVAKM LLKMGQEGVP STAAAFILED ALSQRSAMAA VLHVRSHSEV
     PGFFTEGNDV ADSQATFQAY PLREAKDLHT ALHIGPRALS KACNISMQQA REVVQTCPHC
     NSAPALEAGV NPRGLGPLQI WQTDFTLEPR MAPRSWLAVT VDTASSAIVV TQHGRVTSVA
     VQHHWATAIA VLGRPKAIKT DNGSCFTSKS TREWLARWGI AHTTGIPGNS QGQAMVERAN
     RLLKDRIRVL AEGDGFMKRI PTSKQGELLA KAMYALNHFE RGENTKTPIQ KHWRPTVLTE
     GPPVKIRIET GEWEKGWNVL VWGRGYAAVK NRDTDKVIWV PSRKVKPDIT QKDEVTKKDE
     ASPLFAGISD WIPWEDEQEG LQGETASNKQ ERPGEDTLAA NES
//
